“…In addition, we did not have UDS or SF-36 results from the open ONB cohort for comparison, and baseline iONB characterization was not available because of the retrospective nature of the study. While the BCI is a validated instrument, the components added to tailor HRQOL assessment to orthotopic diversion E U R O P E A N U R O L O G Y X X X ( 2 0 1 5 ) X X X -X X X (questions on patterns of pad use and mucus), although published previously [3], are not validated. The above notwithstanding, our evaluation of iONB patients using functional data (not only pad number but also pad size, degree of wetness, and timing of incontinence) and a generic and a reliable bladder cancer-specific HRQOL instrument, and the benchmarking of results against open ONB are unique features of this analysis.…”